Iceland-based international digital therapeutics innovator, Sidekick Health, has partnered with Pfizer Inc., one of the world’s premier innovative biopharmaceutical companies.
This news follows the $55 million Series B funding that Sidekick secured recently in Iceland’s biggest round in 2022. With this, the total funding raised by the company is now $75 million.
As a part of the multimillion-dollar partnership, Sidekick and Pfizer will roll out their integrated digital therapeutics offering that will be launched first in the UK. It will be followed by Belgium, Norway, the Netherlands, Sweden, France, Ireland, and Japan later this year. This marks the next phase of a growing relationship to develop digital patient support programs globally, including expansion into 24 markets by 2024.